Adrenocortical suppression in children with nephrotic syndrome treated with corticosteroids

Ganesh M Krishna1, Aashima Dabas1, Mukta Mantan2

  • 1Department of Pediatrics, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India.

Insights

Children with nephrotic syndrome on alternate day steroids show high rates of adrenal insufficiency. A cumulative steroid dose over 0.22 mg/kg/day indicates a risk for adrenocortical suppression.

Area of Science:

  • Pediatric Endocrinology
  • Pediatric Nephrology
  • Endocrinology

Background:

  • Children with nephrotic syndrome often receive prolonged alternate-day steroid therapy.
  • This necessitates evaluating potential adrenocortical suppression using the adrenocorticotropic hormone (ACTH) stimulation test.

Purpose of the Study:

  • To determine the prevalence of adrenocortical suppression in children with nephrotic syndrome on alternate-day steroids.
  • To identify a predictive threshold for steroid dosage associated with adrenal insufficiency.

Main Methods:

  • A cross-sectional study included 52 children (2-18 years) with steroid-sensitive or resistant nephrotic syndrome in remission.
  • Adrenocortical function was assessed via baseline and post-ACTH stimulation serum cortisol levels.
  • Adrenal insufficiency was diagnosed if 1-hour post-ACTH cortisol was <18.0 µgm/dl.

Main Results:

  • The study found a 50% prevalence of adrenal insufficiency using baseline cortisol and 64% using post-stimulation levels.
  • A cumulative annual prednisolone dose of >0.22 mg/kg/day predicted adrenocortical suppression with an AUC of 0.76.
  • The predictive model demonstrated 63.9% sensitivity and 81.3% specificity.

Conclusions:

  • A significant proportion of children with nephrotic syndrome exhibit adrenal insufficiency when treated with alternate-day steroids.
  • Cumulative steroid intake exceeding 0.22 mg/kg/day on an alternate-day basis is a risk factor for predicting adrenocortical suppression.
Abstract

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.5K
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
2.5K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
120
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
779
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
563